title: Runx2 regulates the gene network associated with insulin signaling and energy homeostasis.
abstract: Glucose intolerance seen in metabolic disorders, such as type II diabetes, is commonly associated with improper execution of the insulin signaling pathway, as well as an imbalance of bone and fat tissues, such that a gain in adipose tissue occurs at the expense of bone loss. Fat-producing adipocytes and bone-forming osteoblasts stem from a common mesenchymal progenitor cell. Runx2 positively regulates the commitment of the mesenchymal cell toward osteogenesis, but its effects on energy homeostasis and the insulin signaling pathway are unknown. To investigate the connection, focused microarray profiling of genes associated with the insulin signaling pathway was performed on calvarial cells from Runx2-null embryonic mice and 3T3-L1 preadipocytes treated with control and insulin-containing media. The microarray showed that addition of insulin resulted in a robust induction of genes (>95%) in 3T3-L1 cells. Surprisingly, Runx2-null cells cultured in control media were at an elevated state of energy metabolism and addition of insulin resulted in a marked suppression of genes required for insulin signaling. Clustering analysis revealed that the suppression occurred at all stages of the insulin pathway, from the receptors and transducers to nuclear effectors and target genes. Taken together, these results demonstrate that Runx2 is central for transduction and execution of the insulin regulatory signal. In conclusion, Runx2 actively regulates the gene network required for glucose metabolism and energy homeostasis in mesenchymal cells.
authors: Department of Oral and Maxillofacial Surgery, School of Dentistry, University of Alabama at Birmingham, Birmingham, AL, USA.
authors: Mitra
authors: M
authors: Adhami
authors: Farah Y
authors: FY
authors: Ghori-Javed
authors: Haiyan
authors: H
authors: Chen
authors: Soraya E
authors: SE
authors: Gutierrez
authors: Amjad
authors: A
authors: Javed
references: Genes Dev. 2010 Jul 1;24(13):1403-17
references: 20595232
references: Mol Endocrinol. 1997 Dec;11(13):1881-90
references: 9415393
references: J Clin Invest. 2000 Feb;105(3):311-20
references: 10675357
references: Curr Diabetes Rev. 2010 May;6(3):144-55
references: 20380629
references: J Biol Chem. 1994 Feb 11;269(6):4634-40
references: 7508445
references: Endocr Rev. 1995 Apr;16(2):117-42
references: 7781591
references: Genes Dev. 1991 Sep;5(9):1538-52
references: 1840554
references: J Clin Invest. 1988 Oct;82(4):1151-6
references: 3049671
references: N Engl J Med. 1991 Sep 26;325(13):938-48
references: 1881419
references: Cell. 2002 Jan 11;108(1):17-29
references: 11792318
references: Annu Rev Biochem. 1977;46:359-84
references: 197878
references: Diabetes Metab Res Rev. 2010 Nov;26(8):622-30
references: 20938995
references: Biochem Biophys Res Commun. 2010 Aug 13;399(1):55-9
references: 20638365
references: Curr Opin Rheumatol. 2008 Jul;20(4):429-34
references: 18525356
references: Cell Biochem Funct. 2010 Jun;28(4):334-41
references: 20517899
references: Nature. 2000 Sep 14;407(6801):202-7
references: 11001060
references: Cell. 1997 May 30;89(5):755-64
references: 9182763
references: Crit Rev Eukaryot Gene Expr. 2004;14(1-2):1-41
references: 15104525